The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose escalation of davoceticept, a conditional CD28 costimulator and dual checkpoint inhibitor, in advanced malignancies (NEON-1).
 
Diwakar Davar
Honoraria - Array BioPharma; Immunocore; Instil Bio; Merck; Tesaro; Vedanta Biosciences
Consulting or Advisory Role - Instil Bio; Shionogi (I); Vedanta Biosciences
Research Funding - Arcus Biosciences; CellSight Technologies; Checkmate Pharmaceuticals; GlaxoSmithKline; Merck; Merck; Zucero Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Application No.: 63/124,231; Enteric Microbiotype Signatures of Immune-related Adverse Events and Response in Relation to Anti-PD-1 Immunotherapy
 
Justin C Moser
Honoraria - Caris Life Sciences
 
Michael Millward
Consulting or Advisory Role - Amgen; BeiGene; Guardant Health; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda; The Limbic
Research Funding - Abbvie (Inst); Akeso Biopharma (Inst); Albion Laboratories (Inst); Alpine Immune Sciences (Inst); Amgen (Inst); Apollomics (Inst); AstraZeneca (Inst); AtriCure (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CStone Pharmaceuticals (Inst); Dizal Pharma (Inst); Eucure Biopharma (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Genfleet Therapeutics (Inst); GlaxoSmithKline (Inst); InventisBio (Inst); Lilly (Inst); Maxinovel (Inst); Novartis (Inst); Relay Therapeutics (Inst); Roche (Inst); Takeda (Inst); Therapim (Inst); Turning Point Therapeutics (Inst); Vivace Therapeutics (Inst); Vivace Therapeutics (Inst)
 
Mark Voskoboynik
Honoraria - MSD
Consulting or Advisory Role - AstraZeneca
 
Nehal J. Lakhani
Consulting or Advisory Role - Ikena Oncology; Innovent Biologics; SK Life Sciences
Research Funding - Alexion Pharmaceuticals (Inst); Alexo Therapeutics (Inst); Alpine Immune Sciences (Inst); Alpine Immune Sciences (Inst); Apexian Pharmaceuticals (Inst); Asana Biosciences (Inst); Ascentage Pharma (Inst); Astellas Pharma (Inst); BeiGene (Inst); Celgene (Inst); Celgene (Inst); Cerulean Pharma (Inst); Constellation Pharmaceuticals (Inst); Coordination Therapeutics (Inst); CytomX Therapeutics (Inst); Epizyme (Inst); Formation Biologics (Inst); Forty Seven (Inst); Genmab (Inst); Genmab (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics (Inst); Ikena Oncology (Inst); Ikena Oncology (Inst); Incyte (Inst); InhibRx (Inst); Innovent Biologics; Innovent Biologics (Inst); Jounce Therapeutics (Inst); LAM Therapeutics (Inst); Lilly (Inst); Livzon (Inst); Loxo (Inst); Macrogenics (Inst); Merck (Inst); Mersana (Inst); Northern Biologics (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Sapience Therapeutics (Inst); Seagen (Inst); Servier (Inst); Shattuck Labs (Inst); Symphogen (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst)
 
Rachel E. Sanborn
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Lilly; EMD Serono; Genentech/Roche; Janssen Oncology; Macrogenics; Mirati Therapeutics; Regeneron; Sanofi/Aventis
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - AstraZeneca
 
Jaspreet Singh Grewal
Speakers' Bureau - Bristol-Myers Squibb; Ipsen
 
Ajita Narayan
Consulting or Advisory Role - Celgene; Curio Science
 
Mario Sznol
Stock and Other Ownership Interests - Actym Therapeutics; Adaptive Biotechnologies; Amphivena; EvolveImmune Therapeutics; GlaxoSmithKline; Intensity Therapeutics; Johnson & Johnson/Janssen; Nextcure; Torque
Consulting or Advisory Role - Abbvie; Adaptimmune; Agenus; Alligator Bioscience; Anaeropharma; AstraZeneca/MedImmune; BioNTech; Boehringer Ingelheim; Boston Pharmaceuticals; Bristol-Myers Squibb; Dragonfly Therapeutics; Genentech/Roche; Genocea Biosciences; Gilead Sciences; immunocore; Innate Pharma; ITeos Therapeutics; Jazz Pharmaceuticals; Lilly; Molecular Partners; Nektar; Numab; OncoSec; Pfizer; Pieris Pharmaceuticals; Pierre Fabre; Sapience Therapeutics; Seagen; SERVIER; Simcha Therapeutics; ST Cube; Targovax; Tessa Therapeutics; Trillium Therapeutics; Verastem; Zelluna
Other Relationship - CEC Oncology; Dava Oncology; Haymarket Media; Physicans' Education Resource
 
Stacey R. Dillon
Employment - Alpine Immune Sciences
 
Keren Schieber
Employment - Alpine Immune Sciences
 
Hany Zayed
Employment - Alpine Immune Sciences
 
Christine Marie Dela Cruz
No Relationships to Disclose
 
Graciela Noemi Perez
No Relationships to Disclose
 
Stanford L. Peng
Employment - Alpine Immune Sciences